{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:32:00Z","timestamp":1793136720784,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007486","name":"Universit\u00e9 Paris-Sud","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007486","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007365","name":"Fondazione IRCCS Policlinico San Matteo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004769","name":"Universit\u00e0 degli Studi di Pavia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["15MCPRP25550044"],"award-info":[{"award-number":["15MCPRP25550044"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20CDA35310387"],"award-info":[{"award-number":["20CDA35310387"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007241","name":"Universit\u00e9 Paris-Saclay","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["RE\/18\/4\/34215"],"award-info":[{"award-number":["RE\/18\/4\/34215"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["SBF004\\1095"],"award-info":[{"award-number":["SBF004\\1095"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000850","name":"National Heart and Lung Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2TR000421"],"award-info":[{"award-number":["KL2TR000421"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2TR002317"],"award-info":[{"award-number":["KL2TR002317"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/15\/59\/31839"],"award-info":[{"award-number":["FS\/15\/59\/31839"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.healun.2022.10.026","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T02:13:24Z","timestamp":1667787204000},"page":"173-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension"],"prefix":"10.1016","volume":"42","author":[{"given":"Kellen","family":"Hirsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Nolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Ralph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8860-405X","authenticated-orcid":false,"given":"William A.","family":"Altemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas W.","family":"Morrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3926-1171","authenticated-orcid":false,"given":"Martin R.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2541-4221","authenticated-orcid":false,"given":"Samuel G.","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2022.10.026_bib0001","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1183\/09031936.00072709","article-title":"Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation","volume":"35","author":"Thenappan","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.10.026_bib0002","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.10.026_bib0003","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.201705-0943OC","article-title":"Features and outcomes of methamphetamine-associated pulmonary arterial hypertension","volume":"197","author":"Zamanian","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.10.026_bib0004","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.22069","article-title":"Clinical differences between idiopathic and scleroderma-related pulmonary hypertension","volume":"54","author":"Fisher","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.healun.2022.10.026_bib0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.10.026_bib0006","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/eurheartj\/eht437","article-title":"Pulmonary hypertension related to congenital heart disease: a call for action","volume":"35","author":"Dimopoulos","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2022.10.026_bib0007","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.healun.2017.02.016","article-title":"The Giessen Pulmonary Hypertension Registry: survival in pulmonary hypertension subgroups","volume":"36","author":"Gall","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.026_bib0008","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/eurheartj\/ehq170","article-title":"Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension","volume":"31","author":"Montani","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2022.10.026_bib0009","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.healun.2014.10.003","article-title":"Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the \u201cclassic\u201d responders","volume":"34","author":"Halliday","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.10.026_bib0010","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.hlc.2012.09.004","article-title":"5\u2019UTR repeat polymorphisms of the BMPR2 gene in children with pulmonary hypertension associated with congenital heart disease","volume":"22","author":"Limsuwan","year":"2013","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.healun.2022.10.026_bib0011","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1183\/09031936.04.00018604","article-title":"BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease","volume":"24","author":"Roberts","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.10.026_bib0012","first-page":"2379","article-title":"Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations","volume":"29","author":"Morse","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.healun.2022.10.026_bib0013","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1164\/rccm.201507-1456OC","article-title":"Comparison of treatment response in idiopathic and connective tissue disease-associated pulmonary arterial hypertension","volume":"192","author":"Rhee","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.10.026_bib0014","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.10.026_bib0015","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1164\/rccm.201701-0150WS","article-title":"Enhancing insights into pulmonary vascular disease through a precision medicine approach. A joint NHLBI-Cardiovascular medical research and education fund workshop report","volume":"195","author":"Newman","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.10.026_bib0016","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1164\/rccm.201311-1954ST","article-title":"An official American Thoracic Society Statement: pulmonary hypertension phenotypes","volume":"189","author":"Dweik","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.10.026_bib0017","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endor","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2022.10.026_bib0018","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02004-2018","article-title":"Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.10.026_bib0019","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/2045893217697708","article-title":"Identifying \u201csuper responders\u201d in pulmonary arterial hypertension","volume":"7","author":"Halliday","year":"2017","journal-title":"Pulm Circ"},{"key":"10.1016\/j.healun.2022.10.026_bib0020","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.10.026_bib0021","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/14017431.2017.1359419","article-title":"Angiogenic and inflammatory biomarkers in the differentiation of pulmonary hypertension","volume":"51","author":"S\u00e4leby","year":"2017","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.healun.2022.10.026_bib0022","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1513\/AnnalsATS.201508-543OC","article-title":"Prognostic significance of biomarkers in pulmonary arterial hypertension","volume":"13","author":"Al-Naamani","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.healun.2022.10.026_bib0023","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/2045-8932.110445","article-title":"Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension","volume":"3","author":"Malhotra","year":"2013","journal-title":"Pulm Circ"},{"key":"10.1016\/j.healun.2022.10.026_bib0024","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00408-010-9232-9","article-title":"CXC-chemokine ligand 10 in idiopathic pulmonary arterial hypertension: marker of improved survival","volume":"188","author":"Heresi","year":"2010","journal-title":"Lung"},{"key":"10.1016\/j.healun.2022.10.026_bib0025","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","article-title":"Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension","volume":"122","author":"Soon","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.026_bib0026","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1183\/13993003.00187-2015","article-title":"New potential diagnostic biomarkers for pulmonary hypertension","volume":"46","author":"Tiede","year":"2015","journal-title":"Eur Respir J"},{"issue":"25","key":"10.1016\/j.healun.2022.10.026_bib0027","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2022.10.026_bib0028","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting survival in patients with pulmonary arterial hypertension: The REVEAL Risk Score Calculator 2.0 and comparison with ESC\/ERS-Based Risk Assessment Strategies","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.healun.2022.10.026_bib0029","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/aje\/kwf113","article-title":"Multi-Ethnic Study of Atherosclerosis: objectives and design","volume":"156","author":"Bild","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.healun.2022.10.026_bib0030","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.202105-1118OC","article-title":"Using the plasma proteome for risk stratifying patients with pulmonary arterial hypertension","volume":"205","author":"Rhodes","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.10.026_bib0031","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1164\/rccm.202109-2106OC","article-title":"Mining the plasma proteome for insights into the molecular pathology of pulmonary arterial hypertension","volume":"205","author":"Harbaum","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.10.026_bib0032","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension","volume":"151","author":"Humbert","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2022.10.026_bib0033","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020957234","article-title":"Role of biomarkers in evaluation, treatment and clinical studies of pulmonary arterial hypertension","volume":"10","author":"Hemnes","year":"2020","journal-title":"Pulm Circ"},{"key":"10.1016\/j.healun.2022.10.026_bib0034","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01761-2019","article-title":"Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension","volume":"55","author":"Simpson","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.10.026_bib0035","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/rheumatology\/keaa270","article-title":"Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk","volume":"60","author":"Wienke","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.healun.2022.10.026_bib0036","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13075-022-02734-9","article-title":"Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension","volume":"24","author":"Kolstad","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.healun.2022.10.026_bib0037","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00314-2020","article-title":"IL-6 in pulmonary hypertension: Why novel is not always best","volume":"55","author":"Toshner","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2022.10.026_bib0038","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1161\/CIRCULATIONAHA.104.495887","article-title":"Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation","volume":"111","author":"Khurana","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2022.10.026_bib0039","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.10.026_bib0040","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm731","article-title":"Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1","volume":"8","author":"Luttun","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.healun.2022.10.026_bib0041","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s42255-019-0102-3","article-title":"Endothelial TGF-\u03b2 signalling drives vascular inflammation and atherosclerosis","volume":"1","author":"Chen","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.healun.2022.10.026_bib0042","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40364-017-0112-9","article-title":"Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients","volume":"5","author":"Lim","year":"2017","journal-title":"Biomark Res"},{"key":"10.1016\/j.healun.2022.10.026_bib0043","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2213-2600(17)30161-3","article-title":"Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study","volume":"5","author":"Rhodes","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.healun.2022.10.026_bib0044","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/art.23303","article-title":"Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases","volume":"58","author":"Jais","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.healun.2022.10.026_bib0045","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/CIRCRESAHA.118.313911","article-title":"Discovery of distinct immune phenotypes using machine learning in pulmonary arterial hypertension","volume":"124","author":"Sweatt","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.healun.2022.10.026_bib0046","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/bmjebm-2019-111264","article-title":"On reporting and interpreting statistical significance and p values in medical research","volume":"26","author":"Aguinis","year":"2021","journal-title":"BMJ evidence-based Med"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822022069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822022069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:14:28Z","timestamp":1762355668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249822022069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1053249822022069"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2022.10.026","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2022.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}